UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of CD117-negative gastrointestinal stromal tumors

World journal of gastroenterology : WJG, 2005-02, Vol.11 (7), p.1052

2005

Volltextzugriff (PDF)

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

Annals of surgical oncology, 2008-04, Vol.15 (4), p.1064-1069

2008

Volltextzugriff (PDF)

Identification of Human-Specific Adaptation Sites of ATP6

Annals of the New York Academy of Sciences, 2005-05, Vol.1042 (1), p.142-147

2005

Volltextzugriff (PDF)

ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Mitochondrion, 2007-07, Vol.7 (4), p.273-278

2007

Volltextzugriff (PDF)

Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds

Biochemical pharmacology, 1992-04, Vol.43 (7), p.1613-1620

1992

Volltextzugriff (PDF)

Analysis of disease-associated ND4 mutations: how do we know which mutation is pathogenic?

Mitochondrion, 2007-02, Vol.7 (1-2), p.151-156

2007

Volltextzugriff (PDF)

Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5.) By Antitumor Quinones

Free radical research, 1990, Vol.8 (4-6), p.365-372

1990

Volltextzugriff (PDF)

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin: Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity

Biochemical pharmacology, 1992-04, Vol.43 (7), p.1621-1626

1992

Volltextzugriff (PDF)

1 – 8 von 8

Menü

Weitere Dienste

Einstellungen

Analysis of CD117-negative gastrointestinal stromal tumors

PIK3CA Exon 20 Mutation is Independently Associated with a Poor Prognosis in Breast Cancer Patients

Identification of Human-Specific Adaptation Sites of ATP6

ND4 mutation in transitional cell carcinoma: Does mitochondrial mutation occur before tumorigenesis?

Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds

Analysis of disease-associated ND4 mutations: how do we know which mutation is pathogenic?

Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5.) By Antitumor Quinones

Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin: Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity

Aktive Filter

Suchergebnisse filtern